Companies: 10,795·Total market cap: $144.5T
Clene Inc.

Clene Inc.

CLNNNASDAQHealthcare● Active
$5.33
$-0.12(-2.20%)
Market Cap$54939998
P/E Ratio
52W High$13.5
52W Low$3.25

Clene Inc. (CLNN) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CLNN · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.20M$0.34M$0.65M$0.47M$0.72M
Cost of Revenue$0.04M$0.07M$0.12M$0.03M$0.29M
Gross Profit$0.16M$0.27M$0.53M$0.45M$0.43M
Gross Margin %(computed)78.50%79.53%81.50%94.50%60.03%
Operating Expenses
R&D Expenses$14.01M$20.06M$26.66M$31.92M$28.42M
G&A Expenses$9.23M$13.31M$14.42M$16.16M$18.81M
Total Operating Expenses$23.24M$33.37M$41.07M$48.86M$50.41M
Operating Income($23.08M)($33.09M)($40.54M)($48.41M)($49.98M)
Operating Margin %(computed)
Interest Income$0.22M$0.86M$1.39M$0.00M$0.00M
Interest Expense$2.68M$4.06M$4.56M$3.30M$0.87M
Income Before Tax($26.17M)($39.40M)($49.50M)($29.92M)($10.17M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M($0.43M)
Net Income($26.17M)($39.40M)($49.50M)($29.92M)($9.74M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.65$-5.67$-9.43$-4.69$-3.16
Wtd Avg Shares9.86M6.95M5.25M3.26M3.08M
EBITDA($21.59M)($33.69M)($43.24M)($25.60M)($8.34M)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M

Explore more Clene Inc. data

About Clene Inc. (CLNN) Income Statement

Clene Inc. (CLNN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLNN reported revenue of $0.00B, gross profit of $0.00B (gross margin 78.50%), and net income of ($0.03B) — a net profit margin of -13086.50%.

Frequently asked questions

CLNN · 4 questions

Clene Inc. (CLNN) reported revenue of $0.00B for 2025, down 41.5% year-over-year.

CLNN revenueCLNN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09